SALT LAKE CITY (AP) — The owner and CEO of a Utah pharmacy has been accused of mislabeling large amounts of malaria drugs imported from China that outgoing President Donald Trump incorrectly touted last year as a “miracle” treatment for the coronavirus. Dan Richards, the operator of Meds In Motion, was charged Monday with a misdemeanor for receiving large amounts of chloroquine and hydroxychloroquine from an unregistered manufacturer in China that were incorrectly labeled as Boswellia serrata extract, an herbal supplement. Richards’ attorney, Greg Skordas, says his client was trying to help state leaders who thought the drug could be a good treatment for the virus.
January 13, 2021 /Coronavirus (COVID-19) related news and sports stories, Local News
Utah pharmacy CEO accused of mislabeling hydroxychloroquine
Search
Categories
- Events (84)
- Morning Show (1)
- News (32,486)
- Coronavirus (COVID-19) related news and sports stories (533)
- COVID-19 Services Available (2)
- Featured News (1,559)
- Local News (11,026)
- National News (21,263)
- Promotions (5)
- Sounds of Sunday (1,330)
- Conference Reports (493)
- Sunday Fireside (380)
- Sunday Forum (457)
- Sports (12,058)
- Outdoor Corner (10)
- Scores & Schedules (55)
- Sports News – Local (9,328)
- Sports News – National (2,675)
- Uncategorized (124)
Recent Posts
- April 8, 2026
Utah 2034 Steering Committee Maps Out Next Steps
- April 8, 2026
Utah Gas Now Averaging $4.24 Per Gallon
- April 8, 2026
Lake Powell Could Have Worst Water Year Ever
- April 7, 2026
Utah Ranked Top State for Remote Work
- April 6, 2026
Trump Requests $1B For Great Salt Lake












